The Lancet Respiratory Medicine

Pulmonary and Respiratory Medicine

The Lancet Respiratory Medicine (2027)

Editor in Chief: Emma Grainger

The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News.The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print.

Global Print Circulation
950
Avg. Global Monthly Visits
66,799
Avg. Global Monthly Unique Visitors
50,061
Avg. Global Monthly Page Views
114,318
Avg. Global eTOC Distribution
76,912
Circulation updated on 1st October 2026, based on 12-month monthly average October 2025-September 2026, eTOC Metrics: 12 Month Average of eTOC sends - October 2025 to September 2026, Monthly average web metrics based on the period of October 2025 to September 2026